Systemic lupus erythematosus (SLE) is a multifactorial disease that is the result of an interaction between environmental factors and multiple genes involved in the generation of the immune and inflammatory responses. New molecular and genetic approaches have provided a means for mapping genetic loci contributing to SLE in humans as well as in animal models. The hypothesis for this study is that potential loci identified from association and linkage studies in humans and animals can be used to identify candidate genes and/or chromosomal regions contributing to SLE susceptibility, autoantibody production, and the development of coronary vasculitis/atherosclerosis, autoantibody production, and lipid alterations in the MRL/lpr mouse model for SLE can be identified using quantitative trait locus (QTL) mapping. These murine loci can then be tested for linkage in the human SLE multiplex families.
The specific aims for this proposed study are the following: 1. Initiate linkage studies in human SLE multiplex families using candidate genes and chromosomal regions linked to autoantibody production and GN in murine models of SLE. Testing for linkage to SLE susceptibility, development of GN, and autoantibody production in these families will performed using sib-pair linkage analysis with microsatellite markers. Initial candidate genes and regions to be tested include the MHC Class II region on chromosome 6p, selected regions of chromosome 1q, chromosome 10q23-24, and chromosome 19q13. 2. Complete QTL mapping of murine loci in the F2 intercross progeny from MRL/lpr x BALB/c contributing to coronary vasculitic/therosclerotic lesion development; anti-ssDNA and anti-dsDNA antibodies; and cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglyceride levels. A complete genomic linkage map using microsatellite markers at 10-20 cM intervals will be generated and used for mapping. 3. Novel loci identified in the MRL/lpr cross contributing to the autoantibody production will be used to identify candidate genes or chromosomal regions to be tested for linkage in the SLE multiplex families.

Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Jawaheer, Damini; Maranian, Paul; Park, Grace et al. (2010) Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter? J Rheumatol 37:2475-85
Ranganath, Veena K; Yoon, Jeonglim; Khanna, Dinesh et al. (2007) Comparison of composite measures of disease activity in an early seropositive rheumatoid arthritis cohort. Ann Rheum Dis 66:1633-40
Kahn, Katherine L; MacLean, Catherine H; Liu, Honghu et al. (2007) The complexity of care for patients with rheumatoid arthritis: metrics for better understanding chronic disease care. Med Care 45:55-65
Kahn, K L; Maclean, C H; Wong, A L et al. (2007) Assessment of American College of Rheumatology quality criteria for rheumatoid arthritis in a pre-quality criteria patient cohort. Arthritis Rheum 57:707-15
Kahn, K L; MacLean, C H; Liu, H et al. (2006) Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice. Arthritis Rheum 55:884-91
Paulus, Harold E; Oh, MyungShin; Sharp, John T et al. (2004) Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal. Arthritis Rheum 50:1083-96
Liu, Honghu; Harker, Judith O; Wong, Andrew L et al. (2004) Case finding for population-based studies of rheumatoid arthritis: comparison of patient self-reported ACR criteria-based algorithms to physician-implicit review for diagnosis of rheumatoid arthritis. Semin Arthritis Rheum 33:302-10
Riemekasten, Gabriela; Langnickel, Dirk; Enghard, Philipp et al. (2004) Intravenous injection of a D1 protein of the Smith proteins postpones murine lupus and induces type 1 regulatory T cells. J Immunol 173:5835-42
La Cava, Antonio; Ebling, Fanny M; Hahn, Bevra H (2004) Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White)F1 mice suppress in vitro production of antibodies to DNA. J Immunol 173:3542-8
Amjadi-Begvand, Sogol; Khanna, Dinesh; Park, Grace S et al. (2004) Dating the ""window of therapeutic opportunity"" in early rheumatoid arthritis: accuracy of patient recall of arthritis symptom onset. J Rheumatol 31:1686-92

Showing the most recent 10 out of 111 publications